About
Prenatal, Cancer Diagnostics
Areas of Focus
Categories
Diagnostics
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
4
As Collaborator
4
Total Enrollment
473
By Phase
PHASE1/PHASE2: 1PHASE1: 3NA: 2
By Status
COMPLETED: 4RECRUITING: 3NOT_YET_RECRUITING: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07061938Lead Sponsor
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
PHASE1/PHASE2Not yet recruiting
30 participants
Started: Aug 1, 2025 · Completed: Jun 20, 2027
NCT06915311Collaborator
Danish Prognostic Research on Embryonic Diagnostics Involving Chromosomal Testing.
N/ARecruiting
220 participants
Started: Apr 22, 2025 · Completed: May 1, 2030
NCT06415487Lead Sponsor
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
PHASE1Recruiting
30 participants
Started: Aug 22, 2024 · Completed: Mar 27, 2027
NCT05653271Lead Sponsor
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
PHASE1Recruiting
42 participants
Started: Jan 21, 2023 · Completed: Sep 30, 2027
NCT04705935Collaborator
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
N/ACompleted
83 participants
Started: Aug 15, 2022 · Completed: Jun 28, 2024
Locations (1)
Headquarters
Vejle, Denmark
Map
Loading map...